Trial size, ~25 tests:
Click here to buy
Regular size, ~100 tests:
Click here to buy
Caspase 13 activity may be detected in individual cells or suspensions of up to 1x10^6 cells/mL. The noncytotoxic FLICA probe is cell permeant: no lysis or permeabilization steps are necessary. Just culture cells, add FLICA to the media, incubate, and wash. Active caspase 13 enzymes will bind to FLICA and retain it within the cells, thereby capturing the green fluorescent signal. FLICA constantly fluoresces, therefore any unbound reagent must be washed out of the cell to remove any background noise. The resulting positive fluorescent signal can be detected with a fluorescence microscope, a fluorescence plate reader, or a flow cytometer. The green FLICA probe, FAM, excites at 490nm and emits at 520nm.
The FLICA assay also works with adherent cells and very thin tissue sections. FLICA will not work in previously fixed cells or paraffin cells, as those treatments inactivate the caspase 13 enzyme. Please call for details or technical questions at 800-829-3194.
FLICA kits have been used successfully with a multitude of cell lines from a variety of species (human, mouse, rat, etc), including, but not limited to, cancer cells, neurons, primary cells, epithelial cells, endothelial cells, and macrophages. For in vitro apoptosis detection via active poly caspases, see our FLICA Poly Caspases Detection Kits.
Jurkat cells were treated with staurosporine, an apoptosis-inducing agent (bottom), or DMSO, a negative control (top), for 4 hours, then labeled with ICT’s green caspase 13 inhibitor probe, FAM-LEED-FMK, for 1 hour and read on a flow cytometer. Treatment with staurosporine induced caspase 13 activity in 92.7% of the experimental cells (M2, bottom right), whereas the negative control treatment exhibited caspase 13 activity in only 5.4% of the cell population (M2, top right). This is a ratio of 17:1. (Dr. Brian W. Lee, ICT).